孤独症谱系障碍的治疗干预现状与建议  

Treatment and intervention of autism spectrum disorder in China and suggestions for further practice

作　　者：静进[1] JING Jin(Department of Maternal and Child Health,School of Public Health,Sun Yat-Sen University,Guangzhou,Guangdong 510080,China)

机构地区：[1]中山大学公共卫生学院妇幼卫生系,广东广州510080

出　　处：《中国儿童保健杂志》2023年第9期939-944,共6页Chinese Journal of Child Health Care

基　　金：国家社会科学基金重大项目(20&ZD296)。

摘　　要：孤独症谱系障碍(ASD)是一组病因机制未明、异质性高且患病率呈快速递增趋势的神经发育障碍性疾病,其康复矫治主要依赖于早期的教育训练。我国针对ASD的治疗干预尚处于发展阶段,各类医疗和康复教育机构开展了多样化的治疗干预,期望改善ASD的功能并减轻其所带来的家庭和社会负担。基于此,本文对ASD的循证实践进展、我国ASD的治疗干预现状、存在的不足与局限以及未来发展方向做了分析与建议。Autism spectrum disorder(ASD)is a group of neurodevelopmental disorders with unknown etiology,high heterogeneity and rapidly increasing prevalence.Early education and training is the main method of rehabilitation.The intervention for ASD in China is still developing.Various medical and rehabilitation education institutions have carried out a variety of interventions,hoping to improve the function of ASD and reduce the family and social burden caused by ASD.Based on this,this article analyzes and expounds the progress in evidence-based practice of ASD,the current situation of ASD intervention in China,the limitations and the future development direction.

关 键 词：孤独症谱系障碍 神经发育障碍性疾病 循证实践 

分 类 号：R749.94[医药卫生—神经病学与精神病学]